Login / Signup

Assessing the Association Between GLP-1 Receptor Agonist Use and Diabetic Retinopathy Through the FDA Adverse Event Reporting System.

Tiansheng WangWenchao LuHuilin TangJohn B BuseTil StürmerEmily W Gower
Published in: Diabetes care (2018)
Keyphrases
  • diabetic retinopathy
  • adverse drug
  • optical coherence tomography
  • emergency department
  • electronic health record